Previous 10 | Next 10 |
VACAVILLE, CA / ACCESSWIRE / October 3, 2023 / Athena Gold Corporation (OTCQB:AHNR)(CSE:ATHA) (" Athena " or the " Company ") is pleased to announce assay results from a recent reconnaissance and sampling program (the " Program ") at its 100% owned Excelsior Springs Project (" Project ") located...
BOTHELL, Wash., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in the f...
BOTHELL, Wash., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in a...
There was an incomplete headline in the original release VACAVILLE, CA / ACCESSWIRE / September 14, 2023 / Athena Gold Corporation (OTCQB:AHNR)(CSE:ATHA) (" Athena " or the " Company ") is pleased to announce results from its Phase 3 drilling program (the " Program ") at its 100% owned, 4,00...
2023-09-14 13:02:36 ET More on Alzheimer's drug developers Cassava Sciences: Insiders Purchasing Stock, Is The Market Still Buying Simufilam? Prothena: Dunn Appointment And Bristol Opt-In Boost Validation Anavex Life Sciences: Multiple CNS Shots On Goal Awaiting Conv...
VACAVILLE, CA / ACCESSWIRE / September 14, 2023 / Athena Gold Corporation (OTCQB:AHNR)(CSE:ATHA) (" Athena " or the " Company ") is pleased to announce results from its Phase 3 drilling program (the " Program ") at its 100% owned, 4,000 acre Excelsior Springs Gold Project (the " Project " or the...
2023-09-05 17:18:20 ET Gainers: AeroVironment ( AVAV ) +13% . Consolidated Water ( CWCO ) +6% . GitLab ( GTLB ) +6% . Backblaze ( BLZE ) +5% . Gogo ( GOGO ) +5% . Losers: CSG Systems International ( CSGS ) -...
2023-08-11 03:56:11 ET Athira Pharma press release ( NASDAQ: ATHA ): Q2 GAAP EPS of -$0.78 beats by $0.02 . Cash, cash equivalents and investments were $196.3 million as of June 30, 2023, compared with $245.2 million as of December 31, 2022. Net cash used in operat...
Completed end of Phase 2 meeting and continu e d engagement with U.S. Food and Drug Administration Appointed Andrew Gengos as Chief Financial Officer and Chief Business Officer Maintains strong balance sheet to support innovative clinical development pipeline i...
VACAVILLE, CA / ACCESSWIRE / July 19, 2023 / Athena Gold Corporation (OTCQB:AHNR)(CSE:ATHA) (" Athena " or the " Company ") is pleased to announce that it has successfully completed the Company's Spring 2023 reverse circulation (" RC ") drill program of nine (9) angle holes (see press release da...
News, Short Squeeze, Breakout and More Instantly...
Company to provide overview of Phase 2/3 LIFT-AD clinical trial of fosgonimeton in mild-to-moderate Alzheimer’s disease (AD); LIFT-AD topline data expected in second half of 2024 Two key opinion leaders will discuss ongoing unmet medical need and LIFT-AD’s primary endpoint...
BOTHELL, Wash., June 11, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that it has completed the first cohort of healthy ...
BOTHELL, Wash., May 17, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that the U.S. District Court for the Western Distri...